Two-thirds of the iron normally present in the body is in hemoglobin. Hemoglobin turnover is generally accepted to be much greater than turnover of iron in storage depots, in which nearly all of the remaining iron is found. For these reasons it was anticipated that hemoglobin synthesis might be measured directly by means of radioactive iron. The pioneering work of Huff and Elmlinger and their associates (1) (2)(3) proposed that hemoglobin synthesis could be determined from the product of the rate of removal of iron from plasma (plasma iron turnover, milligrams per day) and the fraction of radioactive iron incorporated into circulating erythrocytes. Further studies by Huff and others (4-16), however, revealed that hemoglobin synthesis calculated in this way was consistently greater than would be expected from relating circulating hemoglobin to well established data concerning the life span of erythrocytes. Plasma iron turnover data yielded daily hemoglobin synthesis rates of 1.2 to 2.0 per cent of circulating hemoglobin as contrasted with expected rates of 0.75 to 1.00 per cent corresponding to an erythrocyte life span range of 100 to 130 days (17-20).
Two-thirds of the iron normally present in the body is in hemoglobin. Hemoglobin turnover is generally accepted to be much greater than turnover of iron in storage depots, in which nearly all of the remaining iron is found. For these reasons it was anticipated that hemoglobin synthesis might be measured directly by means of radioactive iron. The pioneering work of Huff and Elmlinger and their associates (1) (2) (3) proposed that hemoglobin synthesis could be determined from the product of the rate of removal of iron from plasma (plasma iron turnover, milligrams per day) and the fraction of radioactive iron incorporated into circulating erythrocytes. Further studies by Huff and others (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) , however, revealed that hemoglobin synthesis calculated in this way was consistently greater than would be expected from relating circulating hemoglobin to well established data concerning the life span of erythrocytes. Plasma iron turnover data yielded daily hemoglobin synthesis rates of 1.2 to 2.0 per cent of circulating hemoglobin as contrasted with expected rates of 0.75 to 1.00 per cent corresponding to an erythrocyte life span range of 100 to 130 days (17) (18) (19) (20) .
Although plasma iron turnover can be used for relative comparisons of erythropoiesis under certain circumstances, it is apparent that plasma iron turnover must be analyzed into its component parts before it can be used for quantitative determination of hemoglobin synthesis. This study was undertaken in an attempt to quantitate hemoglobin synthesis. For this purpose, mathematical models were developed that are compatible with experimental data obtained from over 400 subjects. Sequential measurements of radioiron were made in plasma, red cells, and at the body surface (21, 22) . Data obtained from 13 normal subjects and 6 patients with endogenous hemochromatosis are pre-* This investigation was supported in part by a grant from the United States Public Health Service (C-1440).
sented in this report and analyzed in accordance with the proposed models. Most patients with endogenous hemochromatosis are not anemic and show normal blood and marrow erythrons upon histologic examination, suggesting normal hemoglobin synthesis and erythrocyte life span (23) . Iron kinetics in these patients is greatly altered by a marked pathologic increase of iron stores. Study of patients with endogenous hemochromatosis therefore provides an especially useful test of the proposed iron kinetics model.
MATERIALS AND METHODS
All normal subjects (1 female and 12 male volunteers between the ages of 24 and 72 years) studied with the methods presented are included in this report. All were asymptomatic, in good health, with normal hematologic values.
All patients with endogenous hemochromatosis studied (6 males) are included in this report. None had received blood transfusion or iron therapy. Five of these patients were between 50 and 60 years old, with characteristic slate-grey or leaden, dusky skin color, and diabetes. Diagnosis was established by the abnormally increased concentration of iron in plasma (178 to 278 /Ag per 100 ml), decreased total plasma iron-binding capacity (224 to 278 ,ug per 100 ml), and liver biopsy demonstrating characteristic periportal fibrosis in association with massive deposits of hemosiderin. The sixth patient was only 22 years old; although biopsy of his liver demonstrated markedly increased amounts of hemosiderin, no periportal fibrosis was present. Glucose tolerance and cardiac and hepatic function were normal. Plasma iron concentration (149 sAg per 100 ml) and total binding capacity (314 Ag per 100 ml) were normal; he had not been venesected. The diagnosis was established by demonstration of increased absorption of ingested iron [29 per cent of 4 mg iron (ferrous citrate) without ascorbic acid], in association with a striking familial incidence of endogenous hemochromatosis-his father and one paternal uncle had died with endogenous hemochromatosis and diabetes, and a living paternal uncle is also so affected. More precisely, since no pathologic organ function or morphology was demonstrable, he is classified as being at a prehemochromatotic stage of endogenous hemochromatosis (24) . Ten to 40 uc of radioactive iron (Few), as ferrous citrate or ferric ammonium citrate, specific activity 1 to 15 /Ac per ,ug, was used. This was added to sufficient fresh plasma (the recipient's plasma is used except when it lacks sufficient latent iron-binding capacity) to en- sure binding of all iron to the p,-globulin, transferrin.
After incubation at 37°C for 20 to 30 minutes, 5 to 20 ml of the labeled fresh plasma was injected intravenously with a calibrated syringe. Since iron in the plasma is entirely bound to transferrin, iron was injected in this form to ensure its acting as a true tracer. Others have given radioiron directly by i.v. injection and report that this mode of administration is satisfactory (10, 25) . Perhaps radioiron may be used in this way as a tracer if given slowly so as not to exceed the plasma iron-binding capacity of the small mixing volume in transit from the site of injection to the lungs. During the 10 to 14 days following injection, serial blood samples were analyzed for plasma and erythrocyte radioactivity, and surface measurements of radioactivity over liver, spleen, and sacral bone marrow were made.
Plasma and erythrocyte radioactivity were measured by counting 2-or 3-ml samples in a well scintillation counter, with a 2-inch Nal crystal and 6-inch lead shielding (26) . The counting efficiency was about 25 per cent for Fe'9 and the background approximately 105 cpm. Blood samples were centrifuged at 2,000 G for 15 minutes to obtain plasma free of erythrocytes. It was necessary to take care in drawing and manipulating the blood to avoid hemolysis which, after significant labeling of erythrocytes occurs, would produce erroneously high concentration of radioiron in plasma (Figure 14, . Concentration of iron in plasma and latent iron-binding capacity were determined by the modification of Peters and co-workers of the Ramsey method (27) . Hematocrits were determined on all samples. Plasma and red cell volumes were determined independently by the Fe' and P" dilution methods (28, 29) . Surface used to detect increase of red marrow volume in adults and to check variation of background and instrumentation.
MATHEMATICAL ANALYSIS OF PLASMA RADIOIRON
Study of normal subj ects for whom tracer radioiron was measured in plasma, sacral marrow, liver, spleen, and circulating erythrocytes (Figures 1-4 From these considerations the model in Figure 5a is proposed for normal subjects whenever storage deposition of plasma iron concentration of 70 to 170 ,ug per 100 ml, the fraction of plasma iron removed per hour increasing as total plasma iron decreases, thereby maintaining a constant product.
The mean life span of the erythron is estimated by the ratio of total hemoglobin to daily hemoglobin breakdown. The latter is calculated from the rate of hemoglobin synthesis and the change, if any, in total hemoglobin (Appendix B). The calculation of mean erythron life span involves the assumption that the average rate of hemoglobin breakdown, calculated from measurements during a 2 week period, remains constant during the life span of the erythron. Mean erythron life span in this context signifies the life span corresponding to the calculated average rate of hemoglobin breakdown. The mean time interval between incorporation of iron into marrow erythrons and its appearance in circulating erythrocytes is designated as the mean effective erythron henoglobiniZation time (MEEHT). The method of calculating cumulative net incorporation of radioiron into maturing erythrons and MEEHT is presented in Appendix C. The simpler mathematical model ( Figure 5 ) in which plasma iron exchange with storage pools is neglected can be applied, not only to normal subj ects, but to a variety of conditions in which the normal pattern of iron flow from plasma to marrow to erythrocytes occurs. This includes iron deficiency anemia, primary or secondary polycythemia, and most hemolytic anemias (21, 22, 33, 34) . Premature re-entry of radioiron into plasma results whenever erythron hemolysis occurs, whether in marrow (associated with increased MEEHT) or subsequent to erythron entry into the circulation [frequently associated with delayed increase of splenic counting rate above its initial level; i.e., cpm per cpm)> 1 (22) ]. In hemolytic anemias, feedback of radioiron from destroyed labeled erythrocytes to plasma results in a progressive decrease of the negative plasma radioiron slope (which may even become positive in severe hemolysis), terminating in a constant equilibrium level (22) . Under these circumstances, the exponential components may be approximated by subtraction of the minimal value from the preceding curve.
This mathematical treatment of hemolytic feedback is a simple approximation that is very useful and yields results that agree closely with more complex and precise methods. The approach is not rigorous, since it is apparent that feedback of radioiron from hemolyzed erythrons to plasma is not present at a constant level from time of injection through the entire 2 week period of study. Detailed analysis of this problem, with evaluation of the hemolytic component will be presented separately, together with results obtained in studies of patients with hemolytic anemias (21 Feedback of radioiron from relatively fixed stores to plasma becomes appreciable in 14 to 21 days. Considerations similar to those discussed for hemolytic feedback apply, and xl = Ae-rl' + Be-T2 + C&-st + E[1 -AV(t)] (Figure lib) . Since the final "constant" plasma radioiron level E, resulting from storage feedback, usually occurs at a later time and a lower level than that resulting from hemolytic feedback, a smaller error (less than 5 per cent) is introduced by subtracting this constant minimal value from the preceding curve. A more rigorous and complex mathematical treatment of feedback from relatively fixed stores (compartment 6 illustrated in Figure 6 ) will be presented separately. The amount of storage iron that is miscible in approximately 3 weeks is calculated by relating the "constant" plasma radioiron level E to the fraction of injected radioiron deposited in storage, 1 -f, as shown in Appendix B. In the absence of hemolysis, radioiron continues to be slowly removed from storage reserve and is incorporated via plasma into circulating erythrocytes. The so-called constant plasma level E is, in fact, a slowly decreasing one, but with too shallow a slope to be evident during the 4 to 5 week period of observations.
All radioiron is initially in plasma, and 7 to 10 days later is normally almost entirely in circulating erythrocytes. Initial surface radioactivity rates over liver, spleen, and marrow, cpm0, obtained by extrapolation back to t = 0, are largely the result of radioactivity in plasma circulating through these organs. As radioiron leaves plasma and accumulates in marrow, splenic and hepatic counting rates usually fall, while the sacral counting rate rises rapidly. Subsequently, in zivo counting rates normally return to their initial value, cpm0, when almost all radioiron has returned to the blood (Figures 1, 4 ). For convenience, body surface radioactivity is not expressed as niet radioactivity, cpm -cpm0 X (fraction of radioiron in circulating blood), but rather as the ratio cpm/cpm,.
Expressed in this way, hepatic and splenic radioactivity normally do not exceed 1, sacral radioactivity usually exceeds 2 within 4 hours, and all sites approximate 1 within 10 days ( Figure 4 ). Slow increase of sirface hepatic radioactivity during the first 3 hours after injection, together with simultaneous slow disappearance of radioiron from plasma (small r1), is almost always the result of considerable iron exchange between plasma and stores (Figures 6, 7, 9); while relatively rapid initial hepatic accumulation of radioiron, comparable with the rate of normal sacral accumulation of radioiron, is associated with hemoglobin synthesis in hepatic erythrons and subsequent decrease of hepatic radioactivity (2, 21, 22) . Slow initial increase of hepatic radioactivity (not present in patients with low concentration of iron in plasma) with confirmatory presence of a distinct third exponential component in the plasma radioiron curve, and subnormal incorporation of radioiron into circulating erythrocytes, indicates application of the storage ex-759 MYRON POLLYCOVE AND ROBERT MORTIMER change model ( Figure 11 ). Unless there is gradual initial increase of hepatic radioactivity that persists (Figure 9 ), the "normal flow" model is used ( Figure 5 ). In so neglecting normal storage iron deposition, not more than a 10 per cent error is incurred in calculating hemoglobin synthesis and mean erythron life span, as shown in the Discussion. Because of the experimental error (± 5 per cent) involved in red cell volume determinations used to determine f, it does not seem advantageous to use the storage exchange model for more exact measurement of normal deposition of stored plasma iron.
The storage exchange model involves the variable f, the maximal fraction of inj ected radioiron incorporated into erythrons. When hemolysis is absent, as is the case in 5 of the patients with hemochromatosis, f equals the measured maximal incorporation of radioiron into circulating erythrocytes (Figures 6 and 8 ). If erythrons are destroyed within the 10 day period after incorporation of radioiron, then f is greater than maximal net incorporation of radioiron into circulating erythrocytes. The occurrence of hemolysis usually is evidenced by cessation of the decrease in plasma radioiron and establishment of a constant equilibrium level in 10 days or less (21, 22, 34) . Plasma radioiron would not be expected to reach a constant level in less than 10 days whenever hemolysis is solely the result of a shortened finite erythrocyte life span longer than 10 days. Finite erythrocyte life span is here defined as the occurrence of erythrocyte destruction with normal distribution about a definite time interval after erythron release into the circulation. Occurrence of only this type of hemolysis is probably rare, since complete study of over 400 patients with shortened erythrocyte life span has demonstrated equilibration of plasma radioiron at a constant level within 10 days (21) .
This early stabilization of plasma radioiron is present in this study only in hemochromatotic Patient 59-70 with mild hemolysis resulting in a mean erythron life span of 52 days; plasma radioiron in this patient attains a constant level by Day 9 ( Figure 12 ). In this case f is greater than maximal erythrocyte net incorporation of Hours 4 6 A X 4 radioiron ( Figure 12 ). To arrive at an estimate of f when significant hemolysis and plasma-storage iron exchange are both present, surface measurements may be used as shown in Appendix E. Measurements of radioiron in liver, spleen, marrow, blood, and occasionally lung, are used in an effort to account in rough approximation for the distribution of radioiron in the body throughout the study. With rare exceptions it has been possible to do this in over 400 studies, including cases in which there is loss of radioiron by gastrointestinal bleeding or pulmonary bleeding (21, 28) . These semiquantitative estimates derived from surface counting allow better localization and quantitation of pathologic function and are helpful in selecting the appropriate model and value for f used for quantitative analysis of plasma and erythrocyte radioiron data (Appendix E). Most patients with appreciable hemolysis, however, do not have appreciable plasma-storage iron exchange relative to plasma-erythropoiesis iron exchange, and the "normal flow" model is used-i.e., f = 1.
When the storage exchange model involving the sum of three exponentials is used, the slopes and intercepts obtained from the plasma radioiron curves are quite sensitive to the curve-fitting employed. Although the values for compartment size and transfer rate are very sensitive to errors in the graphically determined slopes and intercepts, these changes are compensatory with respect to the amoounts of iron transferred. For example, if at a given level of plasma radioiron, r3 becomes greater, C also becomes larger, the calculated erythropoietic labile pool (X2) smaller, and the rate constants a2, and a., become larger; the products a2.,X2 (iron fixed for hemoglobin synthesis) and a2,X2 (iron feedback to plasma), however, remain relatively constant. Measurement of the rate of appearance of radioiron in circulating erythrocytes is very useful as an independent rough check of the applicability of the calculated transfer rate from the erythropoietic labile pool compartment (X2) to the fixed erythron iron compartment (X3). This transfer rate into erythrons must be more rapid than the emergence Intercompartmental rate constants were calculated from observed data using the formulae in Appendix D and inserted into the analog computer in both the "storage exchange" and "normal flow" models. The resultant radioiron curves obtained in plasma, labile erythropoietic, and labile storage compartments in the analog computer reproduce within 5 per cent the observed radioiron curves in plasma, sacral marrow, and liver.
DISCUSSION
Mathematical analysis of the proposed general model (Figure 1la ) predicts that tracer radioiron within the plasma iron compartment should decrease with three exponential components when feedback from erythropoietic and storage pools is significant. More than two components are clearly present in the measured plasma radioiron of patients with hemochromatosis in whom significant exchange of iron between plasma and storage compartments is demonstrated by striking hepatic deposition of radioiron ( Figures 6, 9, 10 ). When plasma iron transfer into the storage compartment is negligible, then the general model reduces to the simpler one (Figure 5a ) in which exponential decrease of plasma radioiron contains only two components. Measurements of plasma radioiron in normal subjects, in whom hepatic deposition of radioiron is small, demonstrate only two easily distinguishable exponential components, xi = Ae-rit+ Ce-rst (Figures 1, 2, 5, 14) . Patients with complete erythroid aplasia also demonstrate only two components of plasma radioiron; the slope of the second component, however, corresponds in magnitude to r, and r, is absent (21 ; plasma radioiron, x1 = Ae r1t + Ber2t (Figure 15 ). Using these models, the calculated rates of hemoglobin synthesis, when related to measured totalbody hemoglobin, result in estimates of erythrocyte life spans in normal subjects and patients with endogenous hemochromatosis within the previously established normal range of 100 to 130 days (17, 19 whose plasma radioiron remained constant after Day 9 of the study (Figure 12 ). This corresponds to the "hemolytic" plasma radioiron pattern of Figure 11 . The mean erythron life span of this patient with the "hemolytic" pattern, derived from rate of hemoglobin synthesis and measurements of circulating hemoglobin, was reduced to 52 days. All of the other 18 subjects (13 normal, 5 endogenous hemochromatosis) showed continued decrease of plasma radioiron at Day 10 (Figures 2, 7) .
Patient 60-9, with endogenous hemochromatosis, was venesected 10 days before the study began.
Hemoglobin synthesis in this patient was increased to 11.4 g per day, or 1.6 g per L per day, as compared with 1.3 ± 0.2 g per L per day in normal subjects and 1.4 + 0.2 g per L per day in the other hemochromatotic patients without hemolysis. Relating this increased rate of hemoglobin synthesis to total hemoglobin (759 g) and its increase during the study (4.8 g per day), a mean erythron life span of 114 days was obtained. This demonstrates increased production of erythrocytes with normal longevity in response to venesection. Miscible storage iron in the four patients with advanced endogenous hemochromatosis without hemolysis averaged 4,980 mg. Hepatic ferritin, calculated from data obtained in three patients with endogenous hemochromatosis studied by Finch and Finch (23) , averaged approximately 2,300 mg. Assuming that the liver contains almost half the total storage iron (30) and that ferritin is distributed in approximate proportion to hemosiderin, the value of 4,980 mg obtained for miscible storage iron is not significantly in excess of estimated total ferritin in these patients. It thus appears that very little of the radioiron deposited in storage is fixed in hemosiderin during the 4 week period following injection of radioiron. Using a hepatic hemosiderin: ferritin ratio of 4.5 derived from the data of Shoden, Gabrio and Finch (35) and Finch and Finch (23) and equating ferritin to miscible storage iron, mean total storage iron of 27,400 mg is calculated for the four patients of this study. Using a hepatic hemosiderin: ferritin ratio of 10.6 derived from the data of Heilmeyer in five patients with hemochromatosis (36), total storage iron of 57,700 mg is calculated for these four patients. Miscible storage iron in the fifth patient, 22 years old and classified as prehemochromatotic, is only 820 mg. Assuming that this corresponds to ferritin, and using a smaller hemosiderin: ferritin ratio of 2.0 (35), calculated storage iron in this patient is only moderately increased to 2,460 mg; using the data of Heilmeyer, 4,670 mg. Miscible storage iron was not calculated in the sixth patient (59-70) with hemolysis, in whom a relatively high equilibrium level of plasma radioiron derived from erythron hemolysis is present (D + E, Figure 12 ). This is superimposed upon the lower equilibration level of storage pool radioiron with plasma (E, Figure 10 ) so that storage equilibration could not be measured directly.
The Analysis of earlier ferrokinetic models used for calculating red cell iron turnover and rate of hemoglobin synthesis (1, 2) suggests two reasons for the lack of agreement. The earlier proposal, that rate of iron fixation in erythrocytes is equal to the product of the rate of plasma iron removal and the fraction of radioactive iron found in circulating erythrocytes, implies a linear progression of radioiron from plasma to marrow to red cells without significant feedback. When the return of iron from labile erythropoietic and storage iron pools is neglected, an erroneously large rate of iron fixation in erythrocytes is estimated. In these normal subjects this error averages 52 per cent, while in the patients with endogenous hemochromatosis it averages 22 per cent. Another difficulty arises from equating the maximal fraction of radioiron present in circulating erythrocytes with the maximal fraction of radioiron fixed in maturing erythrons (f). This difference becomes significant in active hemolytic states where maximal net incorporation of radioiron into circulating erythrocytes may be as little as 35 per cent (21), without appreciable initial hepatic deposition of radioiron. Under these circumstances, multiplication of plasma iron turnover by maximal net fraction of radioiron in circulating erythrocytes results in an erroneously small rate of iron fixation in erythrocytes. If, for example, in a patient with negligible plasma-storage iron exchange and severe hemolytic anemia (a23 + a21)/a23 = 6/5 and maximal net incorporation of radioiron into circulating erythrocytes is one-third, then iron fixation in erythrons as calculated by multiplying plasma iron turnover by maximal net incorporation of radioiron into circulating erythrocytes would be only 40 per cent (6/5 X 1/3 X 100 per cent) of the actual iron fixation in erythrons.
In terms of the proposed mathematical models, initial accumulation of radioiron in sacral marrow is largely the result of transfer and equilibration of radioiron between the plasma and labile erythropoietic pools. If this marrow uptake, mirroring disappearance of radioiron from plasma and normally almost complete in 8 hours (Figures 1, 4) , represented irreversible intracellular fixation of radioiron, then release of radioiron from marrow and its appearance in circulating erythrocytes would correspond to the division and maturation times of the various stages of erythron development in which iron is fixed. Since total division and maturation time of erythrons is estimated to be 2.5 to 3.0 days (39, 40) , marrow release and appearance in circulating erythrocytes of radioiron would be complete in approximately 3 days. The observed time of 7 to 10 days required normally for maximal incorporation of radioiron into circulating erythrocytes ( Figure  3 ) is consequently incompatible with the assumption that initial marrow accumulation of radioiron occurs by irreversible intracellular fixation in marrow erythrons. If, on the other hand, a nonerythropoietic labile pool (also a nonstorage labile pool, as shown by absence of considerable hepatic accumulation of radioiron) is postulated to supply radioiron to marrow via plasma at the appropriate rate, then sacral marrow radioiron accumulation would be much more gradual and reduced than that observed (Figure 4) .
The concept of a labile erythropoietic pool is central to the proposed mathematical models.
These models were first presented in 1956 (5, 6) . At that time no morphologic or biochemical entity corresponding to such a pool had been observed. Bone marrow hemosiderin and ferritin were and still are considered part of the iron storage compartment. Subsequently in 1957, Bessis and Breton-Gorius, using electron microscopy, demonstrated that ferritin may be transferred by micropinocytosis from reticulum cells and extracellular fluid into the cytoplasm of maturing erythrons or, possibly, the reverse sequence occurs (41) (42) (43) . It is well established that ferritin is a labile form of iron in equilibrium with ionic iron: Fe+++ + apoferritin ;± ferritin (36, (44) (45) (46) (47) (48) (49) (50) (51) direct transfer of this ferritin from cytoplasm of reticulum cells into cytoplasm of immature erythrons) (43) . It is conceivable, however, that iron from normal destruction in the marrow of a small fraction of maturing erythrons is complexed to ferritin in marrow reticulum cells, and then reincorporated into other erythrons, without entering plasma or labile erythropoietic compartments. This breakdown of hemoglobin during erythron maturation was first suggested by the findings of London, West, Shemin and Rittenberg (68) and Gray, Neuberger and Sneath (69) to explain the early presence in normal subjects of a relatively high specific activity of N15-stercobilin at a time when specific activity of circulating N15-hemin is low; 11 to 20 per cent of total N15-stercobilin being recovered in the initial 8 day period following ingestion of N15-glycine. Other explanations of this finding suggested by these workers are that the stercobilin may be derived from porphyrins not synthesized into hemoglobin or from bile pigment not derived from degradation of a porphyrin ring. When erythron hemolysis occurs in marrow, erythroblastic (or megaloblastic) karyorrhexis and erythrophagocytosis (70) (71) (72) and characteristic uniformity of hemosiderin granulation (73) are seen. The erythrophagocytosis results from the death of erythrons. It is doubtful that viable erythrons are phagocytized (71) . This occurs in pernicious anemia, erythremic myelosis, refractory anemia with erythroid hyperplasia, and thalassemia major (73, 74) . The mean effective erythron hemoglobinization time in these disorders is prolonged markedly (Figure 13) , and plasma radioiron stabilizes in 2 days or less at a high equilibrium level (Figures  5b, D; 16) ; parenteral administration of vitamin B12 to patients with pernicious anemia in relapse results in a prompt exponential decrease of plasma radioiron ( Figure 16 ). These observations suggest that there is relatively little shunting of plasma by iron via the pathway: reticulum cell erythrophagocytosis -> reticulum cell ferritin -* micropinocytosis -> erythron ferritin. Two female patients with clinically mild pernicious anemia were studied. The hemoglobin concentrations were 12.8 and 11.3 g per 100 ml; the hematocrits, 39 and 37 per cent, and red blood cells 3.8 and 3.7 million 768 per mm3. Plasma radioiron in both cases stabilized at a constant equilibrium level in 6 days ( Figure  16 ), in contrast to the exponential decrease of radioiron for approximately 14 days in all 13 normal subjects (Figures 1, 2, 14) . These observations suggest that in normal subjects there is no significant destruction of maturing erythrons with direct reincorporation of all recovered iron, thereby bypassing plasma and labile erythropoietic iron compartments.
There remains the possibility that iron irreversibly fixed in marrow erythrons constitutes the labile erythropoietic pool. If this obtained, then approximately one-third of all iron fixed in erythrons would normally be quickly returned to plasma as a result of destruction of maturing erythrons and only one-quarter of the total number per day (a93 = 0.258, Table I ) would survive to mature and enter the circulation without destruction. This degree of destruction is not compatible with the N15-stercobilin measurements of London (68) and Gray (69) and their colleagues nor with morphologic examinations of normal marrow (70) (71) (72) (73) . Iron is chelated very tightly to transferrin so that no significant dissociation occurs (52, 53) . This precludes the possibility that significant amounts of dissociated Fe59 escape through the capillary walls and become bound to extravascular protein.
One must consider the possibility that a considerable fraction of Fe59-transferrin transfers into the extravascular fluid and that re-entry of radioiron into plasma occurs from this extravascular pool. Transferrin exchange with extravascular extracellular fluid, however, is relatively slow, the halftime being approximately 30 hours (75, 76) . This is quite long compared with 2.5 hours, the longest half-time of initial plasma radioiron decrease observed in patients with hemochromatosis. Less than 10 per cent of the radioiron transfers to extracellular fluid in this patient and approximately only 5 per cent in normal subjects. This is insufficient to explain the prolonged appearance of radioiron in circulating erythrocytes if all erythron radioiron were irreversibly fixed.
Measurements of surface radioactivity in normal subjects show that as radioiron is removed from plasma, hepatic radioactivity usually decreases or, at most, remains constant (Figures 1,  4) . Uptake of radioiron in rib marrow and, to a slight extent, vertebral marrow also contributes to the "hepatic" counting rate. This means that, normally, maximal deposition of radioiron in liver is less than radioiron initially present in hepatic plasma. Since liver contains approximately half of the body iron stores (30) , and on the assumption that blood comprises approximately 18 per cent of liver (1,500 g) (77, 78), we estimate that maximal iron deposition in stores is less than 10 per cent of total fixation of plasma iron in normal subjects. Measurements of net incorporation of radioiron into erythrocytes are in close agreement with this estimate (Figures 1, 3) . Tables I and II , and established data concerning body iron stores (47) , iron absorption (58-67), iron excretion (57, 60) , and plasma globulin exchange with extracellular fluid (75, 76) , the main pathways and compartments may be represented as in Figures 17 and 18 . Corresponding pathways and compartments in patients with endogenous hemochromatosis without hemolysis are illustrated in Figures 19 and 20 . Mean effective erythron hemoglobinization time is the mean time interval between fixation of radioiron in maturing erythrons and appearance of radioiron in circulating erythrocytes. This is shown in Figures 1, 6 , and 13 and calculated in Appendix C. Radioiron enters and is fixed in (37, 38) . Since radioiron enters maturing erythrons at all stages of development, the MEEHT may be expected to be roughly of the order of one-half total erythron division and maturation time. MEEHT of 1.4 0.4 days in normal subjects and 1.6 days in patients with endogenous hemochromatosis were calculated. These are approximately one-half the total erythron division and maturation time.
The delay of radioiron incorporation into circulating erythrocytes which is seen in patients with hemochromatosis probably is not the result of hemolysis of maturing erythrons, delayed erythron maturation, or increased intermitotic interval, since MEEHT is normal. The most probable cause of the delay is the increased time required for removal of radioiron from the increased labile iron pool ( Figure 13 , Appendix C). Conversely, when erythropoiesis is greatly increased, abnormally rapid incorporation of radioiron into circulating erythrocytes probably is not the result of shortened erythron maturation, decreased intermitotic interval, or a decrease in normal destruction of maturing erythrons as suggested by Stohlman (79), since MEEHT is normal ( Figure  13 , sickle cell anemia) (21) . Early delivery into the circulation of a large fraction of reticulocytes and a few nucleated erythrons could conceivably shorten total division and maturation time in the marrow by as much as a full day. Since radioiron is fixed in maturing erythrons at all stages of development, the mean time for radioiron to appear in circulating erythrocytes could be shortened in this way by only one-half or, at the very most, three-quarters of a day. Early release of maturing erythrons cannot be the major factor in reduction of mean time required for appearance of circulating radioiron from 4 days in normal subjects to 2 days in patients with greatly increased erythropoiesis ( Figure 13 , sickle cell anemia). Rapid incorporation of radioiron into circulating erythrocytes is probably largely the result of rapid fixation of radioiron in maturing erythrons-i.e., is increased, in accordance with the proposed mathematical model (Figure 13 , sickle cell anemia, Appendix C). When this occurs, and the mean effective erythron hemoglobinization time is normal-i.e., marrow hemolysis is absent-labeling of erythrons may be complete in a fraction of a day, and the time interval between the maximal Ferritin 771 net incorporation of radioiron into erythrons and maximal net incorporation into circulating erythrocytes furnishes a good estimate of the time required for the earliest labeled cell, the proerythroblast (37), to divide, mature, and enter the blood. This time interval is approximately 3 days, as shown in Figure 13 , sickle cell anemia, and is not appreciably shortened even in the most severe hemolytic anemias (21, 22) . These observations are compatible with the concept that compensatory increased erythropoiesis is the result of increased division of erythroid precursors more immature than proerythroblasts, or increased differentiation of multipotential stem cells into erythroid precursors which then proceed to divide and mature in normal fashion, as proposed by Osgood (80), Alpen and Cranmore (81) and Erslev (82) .
Markedly increased amounts of N15-stercobilin in the first week after ingestion of N15-glycine (83) and markedly increased marrow erythrophagocytosis (70-72) have been observed in patients with pernicious anemia. These observations indicate that marrow hemolysis of maturing erythrons, not prolonged erythron maturation or increased intermitotic interval, is responsible for the marked increase of mean effective erythron hemoglobinization time ( Figure 13 ). The term, mean effective erythron hemoglobinization time, is used because, when hemolysis occurs in marrow, the time interval between initial fixation of some radioiron in maturing erythrons and the appearance of this label in a cell that reaches the circulation may span two or more passages through the marrow maturational pathway (21, 22, 34, 70, 73, 84) .
The calculated amounts of miscible storage iron in the patients with endogenous hemochromatosis correspond closely with estimates of total ferritin derived from direct measurements of hepatic ferritin (23, 35) . The amount of iron calculated to be present normally in the labile erythropoietic pool (84 mg) lies well within the accepted normal range of 750 to 1,500 mg of total-body nonhemoglobin iron (47) . The labile erythropoietic pool was found to be increased to a mean of 117 mg in the 6 patients with endogenous hemochromatosis and reduced markedly in 11 patients with iron-deficiency anemia to a mean of 14 mg (8, 21, 22) . In these iron-deficient patients the mean fraction of labile pool turnover fed back to plasma, a21/(a"23 + ae21), is 0.066 (8, 21, 22) , compared with a normal mean of 0.342. This suggests that the fraction of the total amount leaving the labile pool that is not utilized for hemoglobin synthesis is greatly decreased when the pool size is very small. The distribution and movement of iron, as calculated from mathematical application of the proposed model, appears consistent with established data concerning erythrocyte life span, totalbody nonhemoglobin iron, erythron division and maturation time, and concepts regarding mass action equilibria.
CONCLUSIONS AND SUMMARY
A mathematical model of iron kinetics is proposed and used in the study of 13 normal subjects and 6 patients with endogenous hemochromatosis. Of central importance to this model is the concept of a labile erythropoietic iron pool interposed between iron bound to transferrin in plasma and iron irreversibly fixed in erythrons for heme synthesis. This model is applied to measurements of radioiron in plasma, circulating red cells, and surface counting rates over liver, spleen, and marrow. Together with measurements of plasma iron concentration and red cell volume, this permits calculation of hemoglobin synthesis, mean erythron life span, mean effective erythron hemoglobinization time, storage iron deposition, and miscible storage iron. Results are presented that are in agreement with established concepts concerning the life span of normal erythrocytes, erythron maturation, and body iron stores. Increased storage iron deposition, miscible storage iron, and plasma iron removal were evident in all hemochromatotic patients. Hemoglobin synthesis and erythron life span were normal in five patients with hemochromatosis; one was found to have compensated hemolysis. Erythron hemolysis, whether in marrow, or subsequent to erythron entry into the circulation, may be detected and quantitated by analysis of plasma radioiron, which, as a result of hemolysis, equilibrates at a constant value in 10 days or less. Evidence is presented suggesting that there is insignificant erythron iron bypass of plasma, either by destruction of maturing erythrons in the marrow or via erythrophagocytosis in marrow of circulating erythrocytes.
QUANTITATION OF IRON KINETICS AND HEMOGLOBIN SYNTHESIS APPENDIX A
In this section a mathematical analysis of the kinetics model illustrated in Figure 1 [11] The boundary conditions representing injection of labeled iron into the plasma at t = 0 are: x1(0) = 1; X2(0) = X3(0) = x4(0) = X5(0) = X6(0) = 0. Equations 1 may be solved by using the Laplace transform. With the above boundary conditions, the general solution for compartment 1 is: xl(t) = Ae-rjI + Be-r2t + Ce-r3t.
[2] For the cases in which significant storage of iron occurs the plasma clearance curve can be resolved into three exponential components in agreement with the above equation. The values of A, B, C, ri, r2 and r3 are described by the following equations. The predicted plasma iron curve reduces to a sum of two exponentials.
Xl(t) = Ae-rlit + Ce-r3t. [6] The values of A, C, r1 and r3 are related to the rate constants by the following equations.
Ar3 + Cr1 = a21 + a23 ri + r3 = a12 + a2l + a2.3 rlr3 = a1223. [7] The method of solution of Equations 7 to determine values for the rate constants is described in Appendix D. and a = a56 + a511-3. Miscible storage iron. The constant fraction of radioiron in plasma gradually reached after 2 weeks, E, may be viewed as the result of mixing a fraction of radioiron, 1 -, initially in plasma iron, X1, with a miscible storage pool of iron, Xm*. The time interval between incorporation of iron into marrow erythrons and its appearance in circulating erythrocytes is designated as the mean effective erythron hemoglobinization time (MEEHT). Cumulative incorporation of radioiron into maturing erythrons is calculated from the intercompartmental rate constant a23 and the maximal net incorporation of radioiron into erythrocytes, N..* Nmax, the net fraction of radioiron involved in erythropoiesis is equal to the total fraction involved in erythropoiesis, f, only when hemolysis is absent. N.. is partitioned between a) the combined plasma and labile erythropoietic compartments, and b) the maturing erythron compartment. Since the plasma compartment is usually very small (3 to 5 per cent) relative to the labile erythropoietic compartment, the fraction of the labile erythropoietic compartment fixed each day in maturing erythrons is approximately the same as the fraction of the combined plasma and labile erythropoietic compartments fixed each day in maturing erythrons; i.e., Whenever X2 is not much greater than X1, then the term X2/(X1 + X2)a23 should be substituted for a23 in the following equations. If labile radioiron for erythropoiesis (in plasma and labile erythropoietic pools) is designated as L, and radioiron irreversibly fixed in maturing erythrons is designated as F and net incorporation of radioiron into circulating erythrocytes is designated as N, then, Using this relationship F can be determined for all days of the study. MEEHT = t(N) -t(F) days. Usually a nearly constant maximal time interval has been shown to exist between radioiron net incorporation into erythrons (F) and net incorporation into erythrocytes (N) only in the region of 10 to 30 per cent Nrxax As incorporation continues, the time interval narrows progressively (Figures 1, 6 ). This is to be expected, since radio- In some cases, however, when the erythropoietic labile pool is very small, as in iron deficiency, or when erythron fixation of iron is greatly increased, the intercompartmental rate constant a23 is greatly increased and most of the radioiron is transferred from the labile pool to maturing erythrons in a time which is very short compared with erythron maturation (Figure 13 , sickle cell anemia, pernicious anemia) (22 When X2 is not >> X1, X2/(XI + X2)at23 is used in place of (X23 Mean of 14 patients with severe erythroid hypoplasia or aplasia (21) 2.6 (range 1. 7-4.4) in Table III . These measurements were made with a 1.75-inch diameter scintillation crystal recessed 1.4 inches in lead shielding, 2.5 inches thick, placed as shown in Appendix F. Mean hepatic ratio increase for 100 per cent storage of radioiron is 2.6 as compared with 2.6 in 14 other patients with severe erythroid hypoplasia or aplasia in which hemolysis was slight or absent. Measured net incorporation of radioiron into circulating erythrocytes at 10 days is 0.63. The relatively moderate decrease of net incorporation of radioiron into erythrocytes, from the calculated value of f of 0.74 to the observed net incorporation of 0.63, is consistent with the moderately shortened calculated mean erythron life span of 52 days as judged by 1) theoretical estimation that a 10 per cent decrease of maximal net erythrocyte incorporation corresponds to daily breakdown of 1.5 to 3.5 per cent of newly formed erythrocytes, and 2) observations in many patients with varying degrees of hemolysis and negligible storage iron deposition (21) .
Similar analyses, using splenic ratios derived in patients with erythropoiesis occurring chiefly in spleen or in patients with intense splenic sequestration of erythrocytes, are helpful as a check for estimating f in cases involving both considerable plasma-storage iron exchange and splenic sequestration of erythrocytes. In comparing hepatic and splenic counting rates with sacral counting rates obtained with broad collimation of a 1.75-to 2-inch crystal, it must be kept in mind that the sacral area and adjoining ileum are estimated to represent roughly one-eighth of active marrow, while liver represents roughly one-half of iron storage (35) and is at an average greater distance from the crystal. A factor of approximately one-half should be used for multiplication of hepatic ratio increments as an index of storage for comparison with sacral ratio increments (when red marrow volume is not significantly increased) as an index of erythropoiesis. Similar considerations for spleen lead to the use of factors ranging from one-half to onequarter for comparison of splenic erythropoiesis or splenic sequestration with marrow erythropoiesis (21); enlargement of spleen results in decreased splenic counting rate splenic radioiron remaining constant. 
